Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiming Fan

Showing results (91-100 of 669) with videos related to

Pageof 67
Sort By:
Hepatology (Baltimore, Md.)|February 7, 2012
Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinomaYan Zhao, Man Yang, Xingshun Qi, et al.
Digestion|November 15, 2011
Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trialsZhiping Yang, Qiong Wu, Zhiguo Liu, et al.
Experimental & Molecular Medicine|June 30, 2009
Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progressionZhipeng Wang, Haifeng Jin, Ruodan Xu, et al.
Journal of Cancer|July 2, 2019
The Role of the Slit/Robo Signaling PathwayMingfu Tong, Tie Jun, Yongzhan Nie, et al.
Cancer Letters|March 25, 2014
Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approachesQiong Wu, Zhiping Yang, Yongzhan Nie, et al.
Annals of Gastroenterology|April 16, 2014
Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosisXingshun Qi, Jia Jia, Ming Bai, et al.
Cancer Letters|January 13, 2025
Modulating the gut microbiota: A novel perspective in colorectal cancer treatmentXue Bai, Boyang Liu, Daiming Fan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 30, 2002
[Local cytokines profile in gastric cancer lesions]Xiaoyin Zhang, Yongyi Chen, Yong Liu, et al.
Radiology|August 25, 2015
Integrity of Data in a Randomized Controlled TrialYong Lv, Xingshun Qi, Jielai Xia, et al.
Zhonghua Nei Ke Za Zhi|November 8, 2002
[Antisense inhibition of cyclooxygenase-2 reduces malignant phenotype of gastric cancer cells]Hanping Wu, Kaichun Wu, Liping Yao, et al.
Pageof 67

Showing results (91-100 of 669) with videos related to

Sort By:
Pageof 67
Hepatology (Baltimore, Md.)|February 7, 2012
Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinomaYan Zhao, Man Yang, Xingshun Qi, et al.
Digestion|November 15, 2011
Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trialsZhiping Yang, Qiong Wu, Zhiguo Liu, et al.
Experimental & Molecular Medicine|June 30, 2009
Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progressionZhipeng Wang, Haifeng Jin, Ruodan Xu, et al.
Journal of Cancer|July 2, 2019
The Role of the Slit/Robo Signaling PathwayMingfu Tong, Tie Jun, Yongzhan Nie, et al.
Cancer Letters|March 25, 2014
Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approachesQiong Wu, Zhiping Yang, Yongzhan Nie, et al.
Annals of Gastroenterology|April 16, 2014
Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosisXingshun Qi, Jia Jia, Ming Bai, et al.
Cancer Letters|January 13, 2025
Modulating the gut microbiota: A novel perspective in colorectal cancer treatmentXue Bai, Boyang Liu, Daiming Fan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 30, 2002
[Local cytokines profile in gastric cancer lesions]Xiaoyin Zhang, Yongyi Chen, Yong Liu, et al.
Radiology|August 25, 2015
Integrity of Data in a Randomized Controlled TrialYong Lv, Xingshun Qi, Jielai Xia, et al.
Zhonghua Nei Ke Za Zhi|November 8, 2002
[Antisense inhibition of cyclooxygenase-2 reduces malignant phenotype of gastric cancer cells]Hanping Wu, Kaichun Wu, Liping Yao, et al.
Pageof 67